Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Neoplasms 2 Multiple Myeloma 2 Cancer Pain 2 Squamous Cell Carcinoma of Head and Neck 1 Pain, Postoperative 1 Paget Disease, Extramammary 1 Ovarian Neoplasms 1 Lymphoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Agnosia 1

Interventions

Paclitaxel 79 Carboplatin 64 Bevacizumab 33 liposomal doxorubicin 29 Topotecan 28 Gemcitabine 25 Cisplatin 19 olaparib 18 Drug Therapy 12 Doxorubicin 12 Taxes 11 niraparib 9 Docetaxel 6 CP protocol 6 Trabectedin 5 Hyperthermic Intraperitoneal Chemotherapy 5 Etoposide 5 Cyclophosphamide 5 1-dodecylpyridoxal 5 rucaparib 4 pembrolizumab 4 avelumab 4 atezolizumab 4 Immunoglobulin G 4 Ifosfamide 4 Disulfides 4 Dexamethasone 4 Chemotherapy, Adjuvant 4 trebananib 3 fluzoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ovarian Neoplasms × Acetaminophen × Clear all

NCT06824467 2026-05-29

TroFuse-022

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡